TGF-β1 and VEGF expressions decreased after surgery with improvement in the efficacy; therefore, TGF-β1 and VEGF can be considered as observational indexes and predictors of clinical efficacy in patients with AT rupture before and after surgery (Cui et al., 2019). This evidence concerns the gene TGFB1 and ataxia telangiectasia.